Latest Reports

The third-edition “2022 Ophthalmic Landscape Report” offers a high-level analysis of the 2022 global ophthalmic market by region and subspecialty and forecasts market performance over the next five years. It discusses important trends and key factors for future success.

Market Scope’s "2023 Refractive Error Model" offers extensive country-level prevalence data and five-year forecasts for five refractive error categories by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

The “2023 Optical Coherence Tomography Market Report” provides a comprehensive analysis of the global market for OCT imagers and forecasts market performance over the next five years. It analyzes the market drivers for the OCT segment, including providers, related diseases, competitive forces, and market trends. Market estimates are divided into six categories: basic OCT models, advanced OCT models, combination OCT/fundus systems, combination OCT/SLO systems, intraoperative OCT, and OCTA. Estimates are included for unit sales, installed equipment base, and average prices. Additionally, 12 OCT manufacturers are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2023 Cornea Products Market Report” provides an overview of corneal diseases and gives estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also reviews organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.

This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 12 in-depth company profiles on key market players.

Market Scope in 2023 conducted an online survey of US ophthalmologists focused on diagnostic equipment to better understand industry dynamics, gain important insights into leading trends, and explore surgeons’ opinions on current and future technologies. Sponsors were given the opportunity to review survey questions and add additional questions. Email invitations were sent to US ophthalmologists who had been individually confirmed and verified on market-scope.com to participate in the survey. Email invitations were sent on Nov. 10, 2023. There were 119 total complete, unique responses.

Market Scope’s "2023 Corneal Disease Model" offers extensive country-level prevalence data and five-year forecasts for nine corneal diseases for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Market Scope’s “2023 Dry Eye Products Market Report” analyzes the current marketplace and forecasts market performance through 2028. The report examines dry eye syndrome’s etiology, diagnosis, and treatment and provides in-depth coverage on the prevalence of dry eye, prescription therapeutics, over-the-counter lubricants, thermal expression, IPL, punctum plugs, and additional dry eye procedures and products. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Twenty-nine market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

The report provides a comprehensive analysis of the 2023 global market for ophthalmic surgical instruments—both reusable and disposable—and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery. Product demand is forecast in units and dollars, and market shares are analyzed by product category. The report profiles 31 market competitors—with discussion of their products, strategic market position, background, and outlook—and lists 85 total companies involved in the market segment.

The “2023 Fundus Imaging Market Report” is a specialized supplement, expanding on the fundus imaging section of Market Scope’s comprehensive, global “2023 Ophthalmic Diagnostic Equipment Market Report.”

The report provides background information about fundus imaging devices and divides estimates into five categories: fundus screeners, diagnostic fundus imaging, advanced fundus imaging, combination systems, and hand-held systems. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

Market Scope’s "2023 Retinal Disease Model" offers extensive country-level prevalence data and five-year forecasts for retinal diseases and conditions by age group for all countries with a population over a million.

This proprietary model takes into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models can be used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.